SOLV
SOLVENTUM CORPORATIONNYSEResearch view
Healthcare · Surgical & Medical Instruments & Apparatus · Large-cap · SEC EDGAR FY 2025-12-31
Price history
Chart: TradingView’s own feed · page prices: 1D EOD🔒 Click to interact · scroll moves the page
Snapshot
SEC EDGAR · FY 2025-12-31SectorHealthcare
Market Cap$15.3B
Enterprise Value$19.5B
Income$1.6B
Sales$8.3B
Book/sh$29.66
Cash/sh$5.16
Dividend TTM—
Payout—
Employees—
IPO—
Quick Ratio0.89
Current Ratio1.23
Debt/Eq1.00
EPS (ttm)$8.88
EPS this Y221.7%
EPS past 3/5Y4.5%
Sales past 3/5Y0.8%
EPS Y/Y TTM221.7%
Sales Y/Y TTM0.9%
Shs Outstand170.22M
ROA10.9%
ROE30.8%
ROIC21.5%
Gross Margin53.5%
Oper. Margin26.2%
Profit Margin18.7%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$8.1B
2022
$8.2B
2023
$8.3B
2024
$8.3B
2025
Financials — annual
SEC EDGAR · last 4 FY · tap a row to explain it| USD | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $8.1B | $8.2B | $8.3B | $8.3B |
| Gross Profit | $4.7B | $4.7B | $4.6B | $4.5B |
| Operating Income | $1.7B | $1.7B | $1.0B | $2.2B |
| Net Income | $1.3B | $1.3B | $479.0M | $1.6B |
| Diluted EPS | $7.78 | $7.79 | $2.76 | $8.88 |
| Operating Cash Flow | $1.7B | $1.9B | $1.2B | $369.0M |
| Free Cash Flow | $1.4B | $1.6B | $805.0M | $-10.0M |
Deep dive
Computed from the SEC EDGAR multi-year statementsOperating leverage — margins
GrossOperatingNet
FY25 cash-flow waterfall
Capital-light: capex is $379.0M against $369.0M operating cash
COMMUNITY · $SOLV0 theses
POST YOUR TAKE →Related Stocks
Click to exploreSame Industry · Surgical & Medical Instruments & Apparatus
Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.